Published by Iain Gilbert on 19th August 2021
(Sharecast News) - British drugmaker Sareum said on Thursday that it expects to post a widened full-year loss as a result of increased research-and-development expenditure and delays in compound supply.
URL: http://www.digitallook.com/dl/news/story/32068018/...